Is ENDRA Life Stock a Good Investment?
ENDRA Life Investment Advice | NDRA |
- Examine ENDRA Life's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research ENDRA Life's leadership team and their track record. Good management can help ENDRA Life navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact ENDRA Life's business and its evolving consumer preferences.
- Compare ENDRA Life's performance and market position to its competitors. Analyze how ENDRA Life is positioned in terms of product offerings, innovation, and market share.
- Check if ENDRA Life pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about ENDRA Life's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in ENDRA Life Sciences stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if ENDRA Life Sciences is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very risky | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine ENDRA Life Stock
Researching ENDRA Life's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company has price-to-book ratio of 0.47. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. ENDRA Life Sciences recorded a loss per share of 2966.92. The entity had not issued any dividends in recent years. The firm had 1:35 split on the 7th of November 2024.
To determine if ENDRA Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ENDRA Life's research are outlined below:
ENDRA Life Sciences generated a negative expected return over the last 90 days | |
ENDRA Life Sciences has high historical volatility and very poor performance | |
ENDRA Life Sciences has high likelihood to experience some financial distress in the next 2 years | |
ENDRA Life Scienceshas 841,047 shares shorted by ENDRA Life investors is about 100% of outstending shares | |
Net Loss for the year was (10.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
ENDRA Life Sciences currently holds about 11.28 M in cash with (9.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. | |
ENDRA Life Sciences has a poor financial position based on the latest SEC disclosures | |
Latest headline from seekingalpha.com: ENDRA Life Sciences regains compliance with Nasdaqs listing rule |
ENDRA Life Quarterly Cash And Short Term Investments |
|
ENDRA Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ENDRA Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ENDRA Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
12th of March 2024 Upcoming Quarterly Report | View | |
31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact ENDRA Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises ENDRA Life's investors have experienced.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-05-15 | 2023-03-31 | -1.04 | -0.93 | 0.11 | 10 | ||
2023-08-14 | 2023-06-30 | -0.55 | -0.43 | 0.12 | 21 | ||
2021-08-12 | 2021-06-30 | -1.4 | -1.6 | -0.2 | 14 | ||
2021-11-15 | 2021-09-30 | -1.5 | -1.2 | 0.3 | 20 | ||
2021-05-17 | 2021-03-31 | -1.5 | -1.2 | 0.3 | 20 | ||
2024-03-28 | 2023-12-31 | -0.36 | -0.05 | 0.31 | 86 | ||
2020-11-16 | 2020-09-30 | -3.47 | -3.0 | 0.47 | 13 | ||
2024-08-22 | 2024-06-30 | -3.5 | -4.0 | -0.5 | 14 |
Know ENDRA Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ENDRA Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ENDRA Life Sciences backward and forwards among themselves. ENDRA Life's institutional investor refers to the entity that pools money to purchase ENDRA Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Fmr Inc | 2024-06-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 0.0 | Geode Capital Management, Llc | 2024-09-30 | 0.0 | Virtu Financial Llc | 2024-06-30 | 0.0 | Xtx Topco Ltd | 2024-09-30 | 0.0 | Two Sigma Securities, Llc | 2024-06-30 | 0.0 | Northwestern Mutual Wealth Management Co | 2024-06-30 | 0.0 | Hrt Financial Llc | 2024-06-30 | 329.6 K | Jane Street Group Llc | 2024-06-30 | 116.9 K | Ubs Group Ag | 2024-06-30 | 55.5 K | Susquehanna International Group, Llp | 2024-06-30 | 37.8 K |
ENDRA Life's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.14 M.Market Cap |
|
ENDRA Life's profitablity analysis
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.49) | (1.56) | |
Return On Capital Employed | (1.80) | (1.89) | |
Return On Assets | (1.49) | (1.56) | |
Return On Equity | (1.78) | (1.87) |
Determining ENDRA Life's profitability involves analyzing its financial statements and using various financial metrics to determine if ENDRA Life is a good buy. For example, gross profit margin measures ENDRA Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ENDRA Life's profitability and make more informed investment decisions.
Please note, the presentation of ENDRA Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ENDRA Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ENDRA Life's management manipulating its earnings.
Evaluate ENDRA Life's management efficiency
ENDRA Life Sciences has return on total asset (ROA) of (0.6094) % which means that it has lost $0.6094 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.2013) %, meaning that it created substantial loss on money invested by shareholders. ENDRA Life's management efficiency ratios could be used to measure how well ENDRA Life manages its routine affairs as well as how well it operates its assets and liabilities. As of November 28, 2024, Return On Tangible Assets is expected to decline to -1.56. In addition to that, Return On Capital Employed is expected to decline to -1.89. At present, ENDRA Life's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 3.4 M, whereas Total Assets are forecasted to decline to about 6.6 M.Last Reported | Projected for Next Year | ||
Book Value Per Share | 0.63 | 0.59 | |
Tangible Book Value Per Share | 0.63 | 0.59 | |
Enterprise Value Over EBITDA | -3.4 K | -3.6 K | |
Price Book Value Ratio | 5.9 K | 5.6 K | |
Enterprise Value Multiple | -3.4 K | -3.6 K | |
Price Fair Value | 5.9 K | 5.6 K | |
Enterprise Value | 13.6 B | 19.4 B |
The strategic initiatives led by ENDRA Life's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Beta 0.74 |
Basic technical analysis of ENDRA Stock
As of the 28th of November, ENDRA Life shows the Mean Deviation of 7.3, variance of 191.25, and Standard Deviation of 13.83. Concerning fundamental indicators, the technical analysis model provides you with a way to check possible technical drivers of ENDRA Life, as well as the relationship between them.ENDRA Life's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ENDRA Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on ENDRA Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ENDRA Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ENDRA Life's Outstanding Corporate Bonds
ENDRA Life issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. ENDRA Life Sciences uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most ENDRA bonds can be classified according to their maturity, which is the date when ENDRA Life Sciences has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
ENERGY TRANSFER PARTNERS Corp BondUS29273RAP47 | View | |
ENERGY TRANSFER PARTNERS Corp BondUS29273RAR03 | View | |
ENERGY TRANSFER PARTNERS Corp BondUS29273RAJ86 | View | |
ENERGY TRANSFER PARTNERS Corp BondUS29273RAZ29 | View | |
ENERGY TRANSFER PARTNERS Corp BondUS29273RAT68 | View |
Understand ENDRA Life's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing ENDRA Life's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
Risk Adjusted Performance | (0.06) | |||
Market Risk Adjusted Performance | (1.98) | |||
Mean Deviation | 7.3 | |||
Coefficient Of Variation | (1,076) | |||
Standard Deviation | 13.83 | |||
Variance | 191.25 | |||
Information Ratio | (0.10) | |||
Jensen Alpha | (1.37) | |||
Total Risk Alpha | (3.47) | |||
Treynor Ratio | (1.99) | |||
Maximum Drawdown | 111.83 | |||
Value At Risk | (19.58) | |||
Potential Upside | 12.41 | |||
Skewness | 4.27 | |||
Kurtosis | 28.0 |
Risk Adjusted Performance | (0.06) | |||
Market Risk Adjusted Performance | (1.98) | |||
Mean Deviation | 7.3 | |||
Coefficient Of Variation | (1,076) | |||
Standard Deviation | 13.83 | |||
Variance | 191.25 | |||
Information Ratio | (0.10) | |||
Jensen Alpha | (1.37) | |||
Total Risk Alpha | (3.47) | |||
Treynor Ratio | (1.99) | |||
Maximum Drawdown | 111.83 | |||
Value At Risk | (19.58) | |||
Potential Upside | 12.41 | |||
Skewness | 4.27 | |||
Kurtosis | 28.0 |
Consider ENDRA Life's intraday indicators
ENDRA Life intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of ENDRA Life stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
ENDRA Life Corporate Filings
8K | 22nd of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
21st of November 2024 Other Reports | ViewVerify | |
10Q | 19th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
15th of November 2024 Other Reports | ViewVerify |
ENDRA Stock media impact
Far too much social signal, news, headlines, and media speculation about ENDRA Life that are available to investors today. That information is available publicly through ENDRA media outlets and privately through word of mouth or via ENDRA internal channels. However, regardless of the origin, that massive amount of ENDRA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of ENDRA Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of ENDRA Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to ENDRA Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive ENDRA Life alpha.
ENDRA Life Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards ENDRA Life can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
ENDRA Life Corporate Management
Michael Thornton | Chief Officer | Profile | |
Renaud Maloberti | Chief Commercial Officer | Profile | |
Ziad Rouag | Head Affairs | Profile | |
Jonathan Behr | CoFounder | Profile | |
Richard Jacroux | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share -3 K | Return On Assets (0.61) | Return On Equity (1.20) |
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between ENDRA Life's value and its price, as these two are different measures arrived at by various means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.